Literature DB >> 2817856

Antimicrobial susceptibility of Plesiomonas shigelloides from patients with diarrhea.

K C Kain1, M T Kelly.   

Abstract

Antimicrobial susceptibility testing was performed on 72 fecal isolates of Plesiomonas shigelloides from patients with diarrhea by using a standard agar dilution technique. All isolates were obtained from a single geographic location. Based on the in vitro activities demonstrated in this study, norfloxacin, ciprofloxacin, and trimethoprim may be effective as oral agents in the treatment of P. shigelloides diarrheal disease. For the parenteral treatment of extraintestinal infection, netilmicin and the cephalosporins had the best in vitro activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2817856      PMCID: PMC172711          DOI: 10.1128/AAC.33.9.1609

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

Review 1.  Norfloxacin: a new targeted fluoroquinolone antimicrobial agent.

Authors:  J S Wolfson; D C Hooper
Journal:  Ann Intern Med       Date:  1988-02       Impact factor: 25.391

Review 2.  Plesiomonas: biology of the organism and diseases in children.

Authors:  D McNeeley; P Ivy; J C Craft; I Cohen
Journal:  Pediatr Infect Dis       Date:  1984 Mar-Apr

3.  Plesiomonas shigelloides-associated diarrhea.

Authors:  J F Reinhardt; W L George
Journal:  JAMA       Date:  1985-06-14       Impact factor: 56.272

4.  Plesiomonas enteric infections in the United States.

Authors:  S D Holmberg; I K Wachsmuth; F W Hickman-Brenner; P A Blake; J J Farmer
Journal:  Ann Intern Med       Date:  1986-11       Impact factor: 25.391

5.  The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans.

Authors:  A von Graevenitz; C Bucher
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

Review 6.  Gastroenteritis, sepsis, and osteomyelitis caused by Plesiomonas shigelloides in an immunocompetent host: case report and review of the literature.

Authors:  C W Ingram; A J Morrison; R E Levitz
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

7.  Comparative in vitro activities of selected antimicrobial agents against Aeromonas species and Plesiomonas shigelloides.

Authors:  J F Reinhardt; W L George
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

8.  Clinical features, epidemiology, and treatment of Plesiomonas shigelloides diarrhea.

Authors:  K C Kain; M T Kelly
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

9.  Two epidemics of diarrhoeal disease possibly caused by Plesiomonas shigelloides.

Authors:  T Tsukamoto; Y Kinoshita; T Shimada; R Sakazaki
Journal:  J Hyg (Lond)       Date:  1978-04

Review 10.  Aeromonas hydrophila and Plesiomonas shigelloides as causes of intestinal infections.

Authors:  S D Holmberg; J J Farmer
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct
  10 in total
  4 in total

1.  Plesiomonas shigelloides septicemia and meningitis in a neonate.

Authors:  J D Eason; D Peacock
Journal:  Can J Infect Dis       Date:  1996-11

2.  Plesiomonas shigelloides sepsis and meningoencephalitis in a neonate.

Authors:  C Terpeluk; A Goldmann; P Bartmann; F Pohlandt
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

3.  Isolation and antimicrobial susceptibility of Plesiomonas shigelloides from great cormorants (Phalacrocorax carbo hanedae) in Gifu and Shiga Prefectures, Japan.

Authors:  Ryota Matsuyama; Naotoshi Kuninaga; Tomoya Morimoto; Tetsuya Shibano; Akiko Sudo; Kazunari Sudo; Makoto Asano; Masatsugu Suzuki; Tetsuo Asai
Journal:  J Vet Med Sci       Date:  2015-04-17       Impact factor: 1.267

4.  Gallic acid conjugated with gold nanoparticles: antibacterial activity and mechanism of action on foodborne pathogens.

Authors:  Narintorn Rattanata; Sompong Klaynongsruang; Chanvit Leelayuwat; Temduang Limpaiboon; Aroonlug Lulitanond; Patcharee Boonsiri; Sirinart Chio-Srichan; Siriwat Soontaranon; Supagorn Rugmai; Jureerut Daduang
Journal:  Int J Nanomedicine       Date:  2016-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.